Navigation Links
In-Vitro Metabolism Studies Using Data-Dependent LC/MSn

P.R. Tiller, Thermo Finnigan
W.H. Schaefer, D.M. Murphy, SmithKline Beecham Pharmaceuticals

Metabolite Characterization

The data presented here can be acquired using the Thermo Finnigan LCQ Series of ion trap mass spectrometers.

Introduction

An integral part of the process by which a new drug candidate is evaluated and characterized involves the investigation of its rates and routes of metabolism. Due to their convenience, relative simplicity and reliability, in-vitro systems are used early in the drug discovery process to compare the biotransformation pathways across different species and to gain preliminary information on the metabolic routes to be expected in humans.

The current methodologies to characterize drug metabolites generally utilize LC/MS and LC/MS/MS, but frequently the data obtained is not sufficient to locate the site of metabolism on a candidate molecule. The Thermo Finnigan LCQ Series, with their ability to perform multi-stage MS fragmentation, offer MS3 and MS4 routinely during an HPLC run. These second and third order product ion spectra afford data that allow metabolite identification with greater specificity. An additional strength of the LCQ Series is their ability to perform automated Data-Dependent experiments. This means that the mass spectrometer makes real-time decisions about which MS experiment to perform based on the spectrum just acquired. This approach will be illustrated with the example of the analysis of metabolites derived from glyburide (glibenclamide), a potent sulfonylurea drug.1,2

Goal

In this report, the appli
'"/>

Source:


Page: All 1 2 3 4 5 6

Related biology technology :

1. Big Blue Rodent Cell Cultures for Mutagenesis Studies
2. Precursor miRNAs for Successful miRNA Functional Studies
3. DGGE Analysis for Non-Invasive Studies of Primate Diet
4. Using the DCode System to Identify DNA Sequence Variation for Studies of Population Structure in Marine Organisms
5. SNPs Powerful Tools for Association Studies
6. Low Abundance cDNA Cloned Using Stratagenes Human Universal cDNA Library
7. Oil-Free PCR Using the Hot Top Assembly
8. Functional Cloning Using ViraPort Retroviral cDNA Expression Libraries
9. Signal Transduction Reporting Systems Using Cis-Acting Enhancer Elements
10. Using XL1-Red Mutator Strain to Generate Esterase Variants
11. Detect Released Oligosaccharides Using the Eagle Eye II Still Video Imaging System
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Vitro Metabolism Studies Using Data Dependent MSn

(Date:7/2/2008)...ed on cells manufactured from bone marrow; SV L...SALT LAKE CITY and HAMBURG, Germany, July 2 /PRNew...t the forefront of innovative cell therapies,for t...ed the closing of a,$14.5MM Series A financing. Th...joining the syndicate., "This financing represent...
(Date:7/2/2008)...ma, a leading provider of,knowledge management sol...,industry, announced today that the Aureus Pharma ...er 23rd and 24th., This symposium follows last ye...ttended by many of Aureus, pharmaceutical and biot...The symposium included presentations,from industry...
(Date:7/2/2008)...xpanded Portfolio of Vascular ... July 2 /- Neovasc Inc. (TSXV:,NVC), ...pany developing and,marketing innovative specialty... and the expansion of its product portfolio, as th...r product development companies and the,closing of...
(Date:7/2/2008)...tment R2 levels as a possible p.../ Lorus Therapeutics Inc. (...), a biopharmaceutical company,specializing in the...ts and,technologies for the management of cancer, ...rsity (OSU) clinical team of a paper entitled "Pha...
Breaking Biology Technology:AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury 2AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury 3Aureus Pharma Announces Date of 2008 Annual User Symposium 2Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 2Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 3Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 4Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 2Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 3Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 4Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 5
... , , , , , , Multipora..., , Transfection Protocol ,... , , , , , , ,... line , U937, human leukemic monoblasts...with , Plasmid pEGFP-N1 (in bidistilled...
... , , , , , , Multipora..., , , , , T...4308 915.534 01/2002 , , , ,... , Microorganism , S..., Cell type , Bacteria, gram ...
... , , , , , , Multipora..., , , , , T...4308 915.532 01/2002 , , , ,... , Microorganism , S..., Cell type , Bacteria, gram ...
... , , , , , , Multipora..., , , , , T...4308 915.528 01/2002 , , , ,... , Microorganism , P... Cell type , Bacteria, gram nega...
Other Biology Technology:U937 2Staphylococcus epidermidis 2Salmonella typhimurium 2Pseudomonas aeruginosa 2
(Date:7/3/2008)...ndangered wild orangutan (Pongo spp.) populations ...han previously estimated, according to new finding...scientist Dr. Serge Wich and other orangutan conse...l of Conservation . , , Conservation action ess...e islands of Sumatra and Borneo, must be region-sp...
(Date:7/2/2008)...e in The FASEB Journal provide more evidence tha...nce can improve. According to MIT scientists, diet...infant formula to eggs increase brain synapses and...ains will, like those of experimental animals, res...n synapses and thus restoring cognitive abilities,...
(Date:7/2/2008)...niversity have found that quantum dot nanoparticle...providing insight into potential workplace concern...n the manufacturing of quantum dots or doing resea...ny nanoparticles. , While the study shows that ...e coatings do not penetrate rat skin unless there ...
(Date:7/2/2008)...te, powerful and fast method to automate the analy... Departments of Mechanical and Process Engineering...g experts at IBM,s Zurich Research Laboratory. Th...es density measurements with a large-scale mechani... Using large-scale, massively parallel simulation...
Breaking Biology News(10 mins):Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 2Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 3Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 4Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 5Study shows quantum dots can penetrate skin through minor abrasions 2ETH Zurich and IBM improve diagnosis of osteoporosis 2Global Med Technologies 28R 29 Inc Submits ElDorado Donor 28TM 29 to FDA 4053 1Global Med Technologies 28R 29 Inc Submits ElDorado Donor 28TM 29 to FDA 4053 2Global Med Technologies 28R 29 Inc Submits ElDorado Donor 28TM 29 to FDA 4053 3Stelex Announce QMS Module for Open Texts Livelink ECM 1348 1Stelex Announce QMS Module for Open Texts Livelink ECM 1348 2Stelex Announce QMS Module for Open Texts Livelink ECM 1348 3Spinal cord injury expert to be honored by research foundation 4050 1Spinal cord injury expert to be honored by research foundation 4050 2UTMB researchers to be honored at Oscars of invention 875 1UTMB researchers to be honored at Oscars of invention 875 2
...hnique for analyzing the network of genetic intera...e dynamic biological landscape of the cell. The te...files (E-MAP), has already been used to assign new... previously uncharacterized proteins, and to defin...ith one another. , E-MAP will enable new understa...
...iminary results from a study in Botswana, Harvard ...t people with HIV-1 subtype C in resource-poor set...an achieve comparable results to those in the deve...y system and infrastructure help ensure this succe...ssue of the Journal of Acquired Immune Deficiency ...
...iminary results from a study in Botswana, Harvard ...t people with HIV-1 subtype C in resource-poor set...an achieve comparable results to those in the deve...y system and infrastructure help ensure this succe...ssue of the Journal of Acquired Immune Deficiency ...
...irst time, ultrasound is being used in animal mode...els. Researchers at the University of Pennsylvania...hich they used ultrasound both to see a tumor,s bl...us wave of low-level ultrasound. After three minut... used in physiotherapy ultrasound (about 2.5 watts...
Other Biology News:Technique offers new view of dynamic biological landscape 2Technique offers new view of dynamic biological landscape 3Technique offers new view of dynamic biological landscape 4Largest computational biology simulation mimics life’s most essential nanomachine 2HIV-infected adults in Botswana respond positively to ARV therapy public treatment program 2Penn researchers study the use of ultrasound for treatment of cancer 2
Fluoroskan Ascent FL is equipped with both fluorometric and luminometric measurement technologies that complement the long list of advanced features of Fluoroskan Ascent and Luminoskan Ascent. Fluoro
Wellwash 4 Mk 2 from Thermo Scientific
The Jouan MSC series of Class II Biological Safety Cabinets provides comfortable working conditions and certification to the world's highest safety standards. Fully automatic regulation ensures that
Thermo's orbital shaker stands both present the shaker at a more ergonomic height, and help protect user safety. Purpose-built from welded tubular steel, these heavy-duty accessories are designed to
Biology Products: